Companies making proteins in plants are cooking along, while the agbiotech continues to give itself a black eye. Jeff L. Fox reports.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Immunotherapeutic effects of recombinant colorectal cancer antigen produced in tomato fruits
Scientific Reports Open Access 13 June 2022
-
Development of spirulina for the manufacture and oral delivery of protein therapeutics
Nature Biotechnology Open Access 21 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Beer giant blindsides Ventria's pharmacrop
Agbiotech firms realign product focus
Web links
Rights and permissions
About this article
Cite this article
Fox, J. Turning plants into protein factories. Nat Biotechnol 24, 1191–1193 (2006). https://doi.org/10.1038/nbt1006-1191
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1006-1191
This article is cited by
-
Immunotherapeutic effects of recombinant colorectal cancer antigen produced in tomato fruits
Scientific Reports (2022)
-
Development of spirulina for the manufacture and oral delivery of protein therapeutics
Nature Biotechnology (2022)
-
Plant-derived EpCAM antigen induces protective anti-cancer response
Cancer Immunology, Immunotherapy (2008)
-
Effects of culture media on hCTLA4Ig production and protein expression patterns in transgenic rice cell suspension cultures
Biotechnology and Bioprocess Engineering (2008)
-
Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control
Phytochemistry Reviews (2008)
